Development
A decades-old target falls as hepatitis B is functionally cured in 19%
Claim
GSK's bepirovirsen functionally cured 19% of hepatitis B patients, clearing a hurdle chased for decades and relevant to 300 million people.
Reported metric: 19% functional cure
Reporting date: (not necessarily the event date)
Sources
Attribution and reporting linked by this record; links do not imply independent verification.
- Welcome to June 8, 2026 (theinnermostloop.substack.com)
Cite or correct this record
Suggest a correction — opens a GitHub draft for you to review and submit.